Reevax Pharma Private Limited

Reevax Pharma Private Limited - healthcare in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24239AP2004PTC044249 Incorporated 23 September 2004 ROC Vijayawada HQ Hyderabad, Telangana, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2025
₹4.09 Cr
▲ 23% YoY
Net profit · FY 2025
₹13.79 Lakh
Net margin 3.4%
EBITDA · FY 2025
₹42.5 Lakh
EBITDA margin 10.4%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹1.87 Lakh
Issued & subscribed
Satisfied charges
₹20 Lakh
No open charges
Company age
22 yrs
Est. 2004
Directors on board
2
As per MCA filings

About Reevax Pharma Private Limited

Data last updated:

Reevax Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 23 September 2004 and has been in existence for over 22 years.

The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24239AP2004PTC044249. Its GSTIN is 36AADCR0014R1ZA (Telangana).

The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹1.87 Lakh. It is led by directors Mohan Kumar Tayel and Juhi Tayel.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No: A30 Shankar Towers Associated Industrial Estate Balanagar, Hyderabad, Telangana, India – 500037.

As per the financials filed for FY 2025, the company reported a revenue of ₹4.09 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹13.79 Lakh (net margin 3.4%) and EBITDA of ₹42.5 Lakh (EBITDA margin 10.4%). Revenue has grown at a compounded annual rate (CAGR) of 30% over three years and 27% over five years.

The company is associated with 1 brand: Reevax Pharma. As per MCA filings, the company has satisfied charges of ₹20 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website reevax.com.

Company Details of Reevax Pharma Private Limited
CIN U24239AP2004PTC044249
Registration Number 044249
Incorporation Date 23 September 2004
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    Plot No: A30 Shankar Towers Associated Industrial Estate Balanagar, Hyderabad, Telangana, India – 500037
  • Industry
    Healthcare, Medical Consumables & Supplies
Comprehensive company report
Reevax Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Reevax Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Reevax Pharma Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Reevax Pharma Private Limited

The main business activity of Reevax Pharma is manufacturing. In detail, this covers manufacture of chemicals and chemical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturing20Manufacture of chemicals and chemical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Reevax Pharma Private Limited FY 2025 filings available

Reevax Pharma Private Limited reported revenue of ₹4.09 Cr (up 23% YoY) for FY 2025.

Revenue · FY 2025
₹4.09 Cr ▲ 23%
Net profit · FY 2025
₹13.79 Lakh margin 3.4%
EBITDA · FY 2025
₹42.5 Lakh margin 10.4%

Compounded Annual Growth Rate (CAGR) of Reevax Pharma Private Limited

Revenue CAGR growth
1 year
▲ 23%
3 years · compounded
▲ 30%
5 years · compounded
▲ 27%
EBITDA CAGR growth
1 year
▼ 18%
3 years · compounded
▲ 4%
5 years · compounded
▲ 38%

Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 23% growth in the latest year. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Reevax Pharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹42.5 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹13.79 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Reevax Pharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin10.4%••••••••••••••••
Net Profit Margin3.4%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Reevax Pharma are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Reevax Pharma Private Limited

Reevax Pharma Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Medical Consumables). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Sqube-Bio Healthcare Private Limited₹4.19 Cr (FY 2025)••••••••-43.0%••••Gandhinagar, Gujarat, India
Healplex Life Sciences Private Limited₹4.17 Cr (FY 2025)••••••••23.0%••••Haryana, India
Anondita Healthcare Products Private Limited₹4.16 Cr (FY 2025)••••••••-52.0%••••New Delhi, Delhi, India
Real Hygiene Private Limited₹4.15 Cr (FY 2025)••••••••-19.0%••••Vijapur, Gujarat, India
Medi Shield Health Care Private Limited₹4.12 Cr (FY 2024)••••••••41.0%••••Lucknow, Uttar Pradesh, India
Reevax Pharma Private Limited this company₹4.09 Cr (FY 2025)••••••••23.0%••••Hyderabad, Telangana, India
Sysko Asia Healthcares Private Limited₹4.07 Cr (FY 2025)••••••••16.0%••••Faridabad, Haryana, India
Papier Hygiene Private Limited₹4.06 Cr (FY 2024)••••••••22.0%••••Bangalore, Karnataka, India
Pathkits Healthcare Private Limited₹3.99 Cr (FY 2024)••••••••-9.0%••••Gurgaon, Haryana, India
Cygnet Meditech Private Limited₹3.99 Cr (FY 2025)••••••••7.0%••••Vadodara, Gujarat, India
MJS Latex Private Limited₹3.98 Cr (FY 2025)••••••••-11.0%••••Prantij, Gujarat, India

Peers are the five companies nearest above and the five nearest below Reevax Pharma by revenue in the Healthcare industry (Medical Consumables), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Reevax Pharma Private Limited

Reevax Pharma Private Limited is audited by ALAPATI VADDE & CO for the financial year 2019.

NameStatusAppointment DateCessation Date
ALAPATI VADDE & COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Reevax Pharma Private Limited

Reevax Pharma has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Mohan Kumar TayelDirector21 Mar 201115 Years 6 MonthsCurrent
Juhi TayelDirector12 May 20233 Years 4 MonthsCurrent

Ownership and Shareholding of Reevax Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Reevax Pharma Private Limited

Open charges
None
Satisfied charges
₹20 Lakh
Breakdown by lending institutions
State Bank of India₹0.20 Cr
Latest charge details
DateLenderAmountStatus
10 Mar 2006State Bank of India₹20 LakhSatisfied

Total charge records: 1 View all charges

Associated Brands with Reevax Pharma Private Limited

Reevax Pharma operates one associated brand: Reevax Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Medical device manufacturing focused on wound care and surgical adhesives.reevax.com

Employees and EPFO Compliance at Reevax Pharma Private Limited

Employment history and EPFO contributions of people linked to Reevax Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Reevax Pharma Private Limited

Reevax Pharma Private Limited has 9 board changes on record since 2010: 2 appointments and 7 cessations. The latest: Juhi Tayel ceased to be Additional Director on 03 Sep 2023.

AGM
Reevax Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Reevax Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada.
Ceased
Juhi Tayel ceased to be Additional Director.
Ceased
Jagannath Venkata Surya Yedida ceased to be Director.
Appointed
Juhi Tayel was appointed as Director.
Charges
A charge registered on 10 Mar 2006 via Charge ID 10020614 with State Bank Of India was fully satisfied on 13 Jun 2022.
Ceased
Prem Kumar Bajaj ceased to be Director.
Ceased
Makkara Sada Anand ceased to be Director.
Appointed
Mohan Kumar Tayel was appointed as Director.
Ceased
Venkata Rama Sastry Marty ceased to be Director.
Ceased
Sravan Banda ceased to be Director.
Ceased
Sudha Kiran Banda ceased to be Director.

2 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Reevax Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Reevax Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Reevax Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Reevax Pharma Private Limited

Reevax Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AADCR0014R1ZATelanganaActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Reevax Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reevax Pharma Private Limited

Reevax Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 23 September 2004 (22+ years old) and is registered under CIN U24239AP2004PTC044249.

Reevax Pharma reported revenue of ₹4.09 Cr for FY 2025 (up 23% YoY).

Reevax Pharma has 2 current directors:

Reevax Pharma reported a net profit of ₹13.79 Lakh (net margin 3.4%) and EBITDA of ₹42.5 Lakh (EBITDA margin 10.4%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Reevax Pharma is 30% over three years and 27% over five years. In the latest year (FY 2025) revenue rose 23%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Reevax Pharma is 36AADCR0014R1ZA, registered in Telangana.

The CIN (Corporate Identification Number) of Reevax Pharma is U24239AP2004PTC044249. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Reevax Pharma was incorporated on 23 September 2004, making it 22+ years old. It is registered with the Registrar of Companies, Vijayawada.

The peers of Reevax Pharma by revenue are Sqube-Bio Healthcare Private Limited, Healplex Life Sciences Private Limited, Anondita Healthcare Products Private Limited, Real Hygiene Private Limited, Medi Shield Health Care Private Limited and 5 more, all in the Healthcare industry (Medical Consumables).

Juhi Tayel ceased to be Additional Director on 03 Sep 2023. Jagannath Venkata Surya Yedida ceased to be Director on 12 May 2023. Juhi Tayel was appointed as Director on 12 May 2023. Reevax Pharma has 9 board changes on record in total.

Reevax Pharma can be reached through the website reevax.com. Its registered office is in Hyderabad, Telangana, India.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available